Andreas Voss
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andreas Voss has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
William R. Jarvis
19 shared publicationsSigfrido Rangel-Frausto
17 shared publicationsJan Kluytmans
14 shared publications- Jan Kluytmans3 shared publications
- Jacques F. Meis
Department of Medical Microbiology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
2 shared publications J. A. A. Hoogkamp-Korstanje
University Medical Center St Radboud, Department of Medical Microbiology, PO Box 9101, 6500 HB Nijmegen, The NetherlandsTel: +31-24-3619560 Fax: +31-24-3540216
1 shared publication
Latest Publications
- 1 June 2001
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 22 (6) , 400
SHEA Long-Term–Care Committee
- 1 June 2001
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 22 (6) , 400
SHEA Long-Term–Care Committee
- 1 May 2001
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 22 (5) , 328
SHEA Members Invited to Participate in Joint Conference
- 1 May 2001
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 22 (5) , 328
SHEA Members Invited to Participate in Joint Conference
- 1 March 2001
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 22 (03) , 188
Leapfrog Group Addresses Patient Safety
- 1 March 2001
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 22 (03) , 188
Leapfrog Group Addresses Patient Safety
- 1 February 2001
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 22 (02) , 128
Can the Internet Cause Harm?
- 1 February 2001
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 22 (02) , 128
Can the Internet Cause Harm?
- 2 January 2001
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 22 (1) , 60
Eurosurveillance
- 2 January 2001
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 22 (1) , 60
Eurosurveillance
- 2 January 2001
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 22 (1) , 60
Investment Policy in Tobacco
- 2 January 2001
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 22 (1) , 60
Investment Policy in Tobacco
- 1 December 2000
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 19 (11) , 816-822
Prevalence of Vancomycin-Resistant Enterococci in Europe
The aim of the present study was to determine the prevalence of vancomycin-resistant enterococci (VRE) in Europe. Overall, 49 laboratories in 27 countries collected 4,208 clinical isolates of enterococci. Species identification, susceptibility testing, and van gene determination by polymerase chain reaction were performed in a central laboratory. Overall, 18 vanA and 5 vanB isolates of VRE were found. The prevalence of vanA VRE was highest in the UK (2.7%), while the prevalence of vanB VRE was highest in Slovenia (2%). Most vanA and vanB VRE were identified as Enterococcus faecium. Most VRE isolates originated from the patient's urogenital tract, skin, or digestive tract. VRE were equally distributed among clinical departments, with no clear preponderance in any single patient group. A total of 71 isolates containing the vanC gene were identified. The prevalence of vanC VRE was highest in Latvia and Turkey, where rates were 14.3 and 11.7%, respectively. Two-thirds of these isolates were identified as Enterococcus gallinarum and one-third as Enterococcus casseliflavus; the majority of these isolates were cultured from feces. Almost all isolates were obtained from hospitalized patients, mostly children. The highest prevalence of high-level gentamicin-resistant enterococci was seen in Turkey and Greece. In general, the distribution of this resistance type seemed unrelated to the occurrence of VRE. The prevalence of vanA/vanB VRE in Europe is still low; the majority of the VRE isolates exhibit the vanC genotype and colonize the gastrointestinal tract of hospitalized children.
- 1 December 2000
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 19 (11) , 816-822
Prevalence of Vancomycin-Resistant Enterococci in Europe
The aim of the present study was to determine the prevalence of vancomycin-resistant enterococci (VRE) in Europe. Overall, 49 laboratories in 27 countries collected 4,208 clinical isolates of enterococci. Species identification, susceptibility testing, and van gene determination by polymerase chain reaction were performed in a central laboratory. Overall, 18 vanA and 5 vanB isolates of VRE were found. The prevalence of vanA VRE was highest in the UK (2.7%), while the prevalence of vanB VRE was highest in Slovenia (2%). Most vanA and vanB VRE were identified as Enterococcus faecium. Most VRE isolates originated from the patient's urogenital tract, skin, or digestive tract. VRE were equally distributed among clinical departments, with no clear preponderance in any single patient group. A total of 71 isolates containing the vanC gene were identified. The prevalence of vanC VRE was highest in Latvia and Turkey, where rates were 14.3 and 11.7%, respectively. Two-thirds of these isolates were identified as Enterococcus gallinarum and one-third as Enterococcus casseliflavus; the majority of these isolates were cultured from feces. Almost all isolates were obtained from hospitalized patients, mostly children. The highest prevalence of high-level gentamicin-resistant enterococci was seen in Turkey and Greece. In general, the distribution of this resistance type seemed unrelated to the occurrence of VRE. The prevalence of vanA/vanB VRE in Europe is still low; the majority of the VRE isolates exhibit the vanC genotype and colonize the gastrointestinal tract of hospitalized children.
- 1 September 2000
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 21 (11) , 752
Annual SHEA Meeting—2001
- 1 September 2000
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 21 (11) , 752
Annual SHEA Meeting—2001
- 1 September 2000
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 21 (10) , 688
Federal Action Plan on Antimicrobial Resistance
- 1 September 2000
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 21 (10) , 688
Federal Action Plan on Antimicrobial Resistance
- 1 September 2000
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 21 (10) , 688
In Memorium of Jonathan Freeman
- 1 September 2000
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 21 (10) , 688
In Memorium of Jonathan Freeman